METHOD OF PROGRESSIVE HYPOBIOSIS MODELING FOR HEMATOTHERMAL ANIMALS Russian patent published in 1994 - IPC

Abstract RU 2009546 C1

FIELD: experimental medicine and physiology. SUBSTANCE: α-methyldopa doze value 0,8-1,0 g per 1 kg of animal mass or a-methylparathirozen doze value 100-200 mg per 1 kg of animal mass is injected endo-muscle or endo-peritoneum. When animal comes to poikilothermous state 1-2 hours after first injection second injection is made by serotonin doze equal to 5-10 mg per 1 kg of animal mass. Then animal is immobilized and cooling to achieve narcotized state and animal body temperature can be reduced gradually during 30-40 minutes to 20-22 C without thermogenic reaction (masculine tremor). Physiological exchanging processing level being reduced by 70-80% with respect to normal state hypobiosis state is prolonging down to temperature 17 C (with positive-negative deviations equal to 1 C). When preparation agents are combining by other way time regime schedule is remained. EFFECT: more short time for hypobiosis state attaining equal to 1,5-2,5 hours. 4 cl

Similar patents RU2009546C1

Title Year Author Number
METHOD OF SIMULATING HYPOBIOSIS IN WARM-BLOODED ANIMALS 0
  • Timofeev Nikolaj Nikolaevich
  • Ivleva Valentina Viktorovna
  • Batasheva Tatyana Alekseevna
  • Konstantinov Gennadij Anatolevich
SU1091213A1
METHOD OF SIMULATION OF HYPOTHERMIA 1991
  • Neshina Elena Innokent'Evna
  • Vlasov Boris Jakovlevich
RU2024070C1
0
  • Mitin Yurij Vladimirovich
  • Frantsuzova Stella Borisovna
  • Kvetnoj Igor Moiseevich
  • Mikhajlovskij Dmitrij Olegovich
SU1562345A1
METHOD OF BALANCED REGIONAL ANESTHESIA 1996
  • Shelokhovich Ju.V.
RU2135222C1
"FLUOGLYSINE" MEDICINAL PREPARATION FOR TREATING DIFFERENT FORMS OF DEPRESSION 2002
  • Tolstikov A.G.
  • Tolstikova T.G.
  • Sorokina I.V.
  • Dolgikh M.P.
  • Tolstikov G.A.
  • Fedoseeva L.A.
RU2232574C2
METHOD OF TREATING MAJOR DEPRESSION IN HUMAN 2007
  • Birzhneks Gunter
  • Padke Dipak
  • Polimeropoulos Majkl Kh.
RU2445973C2
TREATING POSTTRAUMATIC STRESS DISORDER 2008
  • Vojvode Tom
  • Moran Mark
RU2458691C2
METHYL ETHER (± ) 7-[2β-[1-AMINO-3-OXO-4-ACETOXI-(1E)-BUTENYL]-5-OXOCYCLOPENTYL-1a]HETANOIC ACID POSSESSING ANTIULCEROUS ACTIVITY 1983
  • Akhrem A.A.
  • Lakhvich F.A.
  • Antonevich I.P.
  • Lis L.G.
  • Kuz'Mitskij B.B.
  • Mizulo N.A.
  • Gorbacheva I.A.
  • Romanova V.N.
  • Frejmanis Ja.F.
SU1221871A1
8-METHYL-8-PHENYL-3-OXOTHIAZOLIDINO-[3,2-A]-PIPERAZINE OR ITS HYDROCHLORIDE SHOWING TRANQUILIZING ACTION 1991
  • Kurojan R.A.
  • Snkhchjan G.M.
  • Mkrtchjan A.K.
  • Markosjan A.I.
  • Engojan A.P.
  • Dzhagatspanjan I.A.
  • Asrjan A.B.
  • Sukasjan R.S.
SU1829361A1
METHOD OF TREATMENT OR PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES BY MEANS OF COMPOUNDS POSSESSING SELECTIVITY WITH RESPECT TO ALPHA-3-SUBUNIT OF BENZODIAZEPINE RECEPTOR 2004
  • Langen Barbara
  • Rundfel'Dt Kris
  • Dost Rita
  • Ljuddens Khartmut
  • Rabe Khol'Ger
RU2354377C2

RU 2 009 546 C1

Authors

Timofeev N.N.

Konstantinov G.A.

Prokop'Eva L.P.

Dates

1994-03-15Published

1989-12-27Filed